IL32020A - Antacid compositions - Google Patents
Antacid compositionsInfo
- Publication number
- IL32020A IL32020A IL32020A IL3202069A IL32020A IL 32020 A IL32020 A IL 32020A IL 32020 A IL32020 A IL 32020A IL 3202069 A IL3202069 A IL 3202069A IL 32020 A IL32020 A IL 32020A
- Authority
- IL
- Israel
- Prior art keywords
- antacid
- composition
- gelation
- magnesium
- viscosity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72217668A | 1968-04-18 | 1968-04-18 | |
US78572768A | 1968-12-20 | 1968-12-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL32020A0 IL32020A0 (en) | 1969-06-25 |
IL32020A true IL32020A (en) | 1972-11-28 |
Family
ID=27110553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL32020A IL32020A (en) | 1968-04-18 | 1969-04-14 | Antacid compositions |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS4621672B1 (no) |
AU (1) | AU438147B2 (no) |
BE (1) | BE731695A (no) |
CA (1) | CA959760A (no) |
CH (1) | CH536114A (no) |
DE (1) | DE1919802A1 (no) |
DK (1) | DK127269B (no) |
ES (1) | ES366173A1 (no) |
FI (1) | FI50831C (no) |
FR (1) | FR2007475A1 (no) |
GB (1) | GB1269987A (no) |
IL (1) | IL32020A (no) |
NL (1) | NL6906087A (no) |
NO (1) | NO129077B (no) |
SE (1) | SE388356B (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1401256A (en) * | 1972-06-30 | 1975-07-16 | Miles Lab | Anticid tablet and preparation thereof |
GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
SE7905972L (sv) * | 1979-07-09 | 1981-01-10 | Haessle Ab | Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand |
JPS62502967A (ja) * | 1985-04-18 | 1987-11-26 | ザ・プロクター・アンド・ギャンブル・カンパニー | 非潰瘍消化不良症の治療 |
IT1215332B (it) * | 1987-01-12 | 1990-02-08 | Crinos Industria Farmaco | Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica |
DE3812378A1 (de) * | 1988-04-14 | 1989-10-26 | Theo Mertens | Mobile erntegutmahl- und -mischvorrichtung |
US4988679A (en) * | 1989-01-03 | 1991-01-29 | Leonard Chavkin | Liquid sustained release composition |
US4980175A (en) * | 1989-01-03 | 1990-12-25 | Leonard Chavkin | Liquid orally administrable compositions based on edible oils |
DE4305919A1 (de) * | 1993-02-26 | 1994-09-01 | Ruediger Potthoff | Transportsilo für Kunststoff-Granulat |
WO2003066022A2 (en) * | 2002-02-04 | 2003-08-14 | Pharmacia Corporation | Stable pharmaceutical composition useful for treating gastrointestinal disorders |
CN1638804A (zh) * | 2002-03-04 | 2005-07-13 | 美德阿利克斯株式会社 | 在生物体内相转移的液态基质以及液态口服制剂 |
US20030232092A1 (en) * | 2002-06-14 | 2003-12-18 | Hasenmayer Donald L. | Liquid antacid compositions |
MX2016013886A (es) | 2014-04-29 | 2017-02-02 | Procter & Gamble | Suspensiones farmaceuticas liquidas que contienen bismuto. |
CA2943420C (en) | 2014-04-29 | 2019-06-25 | The Procter & Gamble Company | Method for making bismuth-containing liquid pharmaceutical suspensions |
CN114732828A (zh) * | 2022-04-27 | 2022-07-12 | 广西南宁百会药业集团有限公司 | 一种铝碳酸镁混悬液及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE621147A (no) * |
-
1969
- 1969-04-14 IL IL32020A patent/IL32020A/en unknown
- 1969-04-14 GB GB09070/69A patent/GB1269987A/en not_active Expired
- 1969-04-15 FI FI691089A patent/FI50831C/fi active
- 1969-04-15 NO NO1526/69A patent/NO129077B/no unknown
- 1969-04-16 AU AU53539/69A patent/AU438147B2/en not_active Expired
- 1969-04-16 CA CA048,813A patent/CA959760A/en not_active Expired
- 1969-04-17 ES ES366173A patent/ES366173A1/es not_active Expired
- 1969-04-17 DK DK209369AA patent/DK127269B/da unknown
- 1969-04-18 SE SE6905549A patent/SE388356B/xx unknown
- 1969-04-18 DE DE19691919802 patent/DE1919802A1/de not_active Ceased
- 1969-04-18 BE BE731695D patent/BE731695A/xx unknown
- 1969-04-18 NL NL6906087A patent/NL6906087A/xx unknown
- 1969-04-18 JP JP3015469A patent/JPS4621672B1/ja active Pending
- 1969-04-18 CH CH593269A patent/CH536114A/fr not_active IP Right Cessation
- 1969-04-18 FR FR6912182A patent/FR2007475A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
FR2007475A1 (no) | 1970-01-09 |
FI50831C (fi) | 1976-08-10 |
GB1269987A (en) | 1972-04-12 |
AU438147B2 (en) | 1973-07-18 |
NL6906087A (no) | 1969-10-21 |
JPS4621672B1 (no) | 1971-06-19 |
FI50831B (no) | 1976-04-30 |
NO129077B (no) | 1974-02-25 |
AU5353969A (en) | 1970-10-22 |
SE388356B (sv) | 1976-10-04 |
DE1919802A1 (de) | 1969-11-06 |
IL32020A0 (en) | 1969-06-25 |
ES366173A1 (es) | 1971-04-01 |
CA959760A (en) | 1974-12-24 |
DK127269B (da) | 1973-10-15 |
BE731695A (no) | 1969-10-20 |
CH536114A (fr) | 1973-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3579634A (en) | Novel antacid compositions and methods for their administration | |
IL32020A (en) | Antacid compositions | |
US3843778A (en) | Antacids | |
US3974272A (en) | Palatable cholestyramine coacervate compositions | |
US5667802A (en) | Antacid composition | |
JPH0535130B2 (no) | ||
CA1259919A (en) | Rehydratable antacid composition | |
IE61062B1 (en) | Pharmaceutical composition containing ibuprofen and aluminium hydroxide | |
US4115553A (en) | Antacid tablets | |
US4869902A (en) | Antacid composition | |
US4705683A (en) | Pharmaceutical compositions | |
US4704278A (en) | Fluidized magaldrate suspension | |
US3272704A (en) | Stable aluminum hydroxide-magnesium compound codried gel antacids and process of making the same | |
AU578690B2 (en) | Antacid composition | |
GB2384986A (en) | Solid compositions for the treatment of disorders of the upper gastrointestinal tract | |
JP2735559B2 (ja) | 懸濁液 | |
GB1582737A (en) | Concentrated magnesium hydroxide suspensions or emulsions and method for production thereof | |
US3326755A (en) | Alginate containing antacid compositions | |
NZ194165A (en) | Antacidaqueous suspension containing aluminium hydroxide | |
US3215601A (en) | Antacid composition and method of making same | |
US4652446A (en) | Pharmaceutical compositions | |
US3245876A (en) | Antacid compositions containing high concentrations of magnesium hydroxide and process of making the same | |
DE69224793T2 (de) | Magnesiumhaltiges Arzneimittel mit verlängerter Wirkstoffabgabe | |
US3208906A (en) | Glycine-stabilized aluminum hydroxidemagnesium compound codried gel antacids and process of making the same | |
JPS61118321A (ja) | 流動化マガルドラート組成物 |